معرفی
Egill Rostrup is a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Psychiatry. His research focuses on understanding the neurobiological mechanisms underlying psychosis and schizophrenia, with particular emphasis on neurotransmitter systems and brain imaging.
Dr. Rostrup's research interests center on the complex interplay between dopaminergic, GABAergic, and glutamatergic systems in psychosis. His work investigates how these neurotransmitter systems relate to treatment response in antipsychotic-naïve patients. He employs advanced neuroimaging techniques to study functional and structural brain connectivity in relation to cognitive functions and symptom profiles in first-episode schizophrenia. His research spans both clinical applications and basic neuroscience to bridge the gap between laboratory findings and patient care.
His recent publications demonstrate a strong focus on translational psychiatry research, particularly examining how brain connectivity patterns predict treatment outcomes. Dr. Rostrup frequently collaborates on multi-center studies like PSYSCAN, which aims to identify biomarkers for psychosis risk and treatment response. His work has significant implications for developing personalized treatment approaches based on neurobiological markers rather than solely symptom presentation. The research output shows consistent contributions to high-impact journals in psychiatry and neuroscience.
Dr. Rostrup has contributed significantly to understanding the trajectory of neurochemical changes during early psychosis treatment and how these relate to clinical outcomes. His research on electroconvulsive therapy has revealed novel insights into how this treatment modality affects brain network connectivity. His work on functional connectivity between auditory networks and medial temporal lobe structures has provided new understanding of the mechanisms underlying auditory verbal hallucinations in schizophrenia.
